Purpose Obstructive sleep apnea (OSA) may contribute to metabolic and inflammatory
deregulation but previous studies failed to consider sleep duration, sleep fragmentation …

Objective To investigate whether sleep‐disordered breathing and/or plasma adiponectin
levels are associated with insulin resistance independent of obesity or fat distribution in …

Purpose Obstructive sleep apnea (OSA) increases the risk for insulin resistance (IR). The
mechanisms that link the two are not clear and are frequently confounded by obesity. OSA is …

Objective: Obstructive sleep apnea (OSA) is associated with obesity, sympathetic activation,
systemic inflammation, and cardiovascular morbidity. Obesity, β‐adrenergic agonists, and …

Background and Objective: There is compelling evidence that obstructive sleep apnoea
(OSA) can affect metabolic syndrome (MetS) and cardiovascular risk, but the intermediate …

Obstructive sleep apnea (OSA) is a common but often unrecognized condition with
potentially serious complications. The aim of this study was to explore the possible …

Obstructive sleep apnea (OSA) is prevalent in obese subjects. Plasma adiponectin level in
obese subjects is decreased. Whether reduced adiponectin level is associated with OSA is …

Objective: To assess the profile of metabolic abnormalities in subjects with obstructive sleep
apnea (OSA). Patients and methods: In a case-control study conducted in two years, from …

Background The relationship between obstructive sleep apnea hypopnea syndrome
(OSAHS) and a variety of disease from obesity, type 2 diabetes mellitus and cardiovascular …

Background Assess if changes in sleep quality (Sleep Quality Index, SQI) based on
cardiopulmonary coupling-analysis (CPC) impacts serum adiponectin-levels in patients with …